Articles From: QAD to Conduct One-on-One Investor Meetings at Benchmark Micro Cap Discovery Conference to Eagle Pharmaceuticals to Discuss 2014 Fourth Quarter and Year-End Financial Results on December 17, 2014


2014/12/10
QAD Inc. (NASDAQ: QADA) (NASDAQ: QADB), a leading provider of enterprise business software and services for global manufacturers, today announced that Pamela Lopker, Chairman of the Board and President, and Daniel Lender, Executive Vice President and Chief Financial Officer, will conduct one-on-one meetings with investors at the Benchmark Company Micro Cap Discovery Conference on Thursday, December 11, 2014 at The Palmer House Hilton in Chicago.
Sign-up for QAD to Conduct One-on-One Investor Meetings at Benchmark Micro Cap Discovery Conference investment picks
2014/12/10
ORRVILLE, Ohio , Dec.
Sign-up for The J. M. Smucker Company Announces Price Increase on K-Cup® Packs investment picks
2014/12/10
CAMBRIDGE, Mass., Dec.
Sign-up for Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock investment picks
2014/12/10
BEACHWOOD, Ohio , Dec.
Sign-up for DDR Declares Fourth Quarter 2014 Class J and Class K Preferred Share Dividends investment picks
2014/12/10
Engility Holdings, Inc. (NYSE:EGL), today announced it has been awarded a $66 million contract to provide technical, management, and analysis support to the John A.
Sign-up for Engility Wins $66 Million Contract to Provide Technical, Management and Analysis Services to Volpe Center investment picks
2014/12/12
VANCOUVER , Dec.
Sign-up for International Tower Hill Mines Closes CAD 8.4 Million Non-Brokered Private Placement investment picks
2014/12/12
WALLKILL, N.Y. , Dec.
Sign-up for Advanced Coating Technologies Recognized by Orange County Partnership for Facility Investment investment picks
2014/12/10
SAN DIEGO, Dec.
Sign-up for Mitek Signs Agreement With NCR to Sell New Mobile Imaging Solutions investment picks
2014/12/10
Regulatory News: Autoliv AB (NYSE:ALV) (STO:ALIVSDB) Autoliv, Inc. (NYSE: ALV, and SSE: ALIV sdb), has set Tuesday May 5, 2015 as the date for its annual meeting of shareholders to be held in Chicago, IL, USA.
Sign-up for Autoliv Sets Date for Shareholder AGM investment picks
2014/12/10
Ono Pharmaceutical Co.,Ltd. (Tokyo: 4528), Bristol-Myers Squibb Company (NYSE:BMY) and Kyowa Hakko Kirin Co., Ltd.
Sign-up for Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immuno-Oncology Clinical Collaboration Studying Opdivo (nivolumab) and Mogamulizumab in Advanced Solid Tumors investment picks
2014/12/10
THOROFARE, N.J., Dec.
Sign-up for Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to China investment picks
2014/12/9
NEW YORK, Dec.
Sign-up for Warren Announces Participation in Upcoming Investor Conference investment picks
2014/12/12
HOUSTON, Dec.
Sign-up for Integrated Electrical Services Reports Fiscal 2014 Fourth Quarter and Year-End Results investment picks
2014/12/12
Activision Publishing, Inc., a wholly owned subsidiary of Activision Blizzard, Inc. (Nasdaq: ATVI ), has delivered the top two selling console retail releases of the year to date overall in the U.S., as well as the #1 kids video game franchise of 2014, based on retail sell-through, according to the NPD Group, through November.
Sign-up for Call of Duty: Advanced Warfare and Destiny Are the #1 and #2 Best-Selling Console Games of the Year in the U.S. investment picks
2014/12/4
SANTA CLARA, Calif., Dec.
Sign-up for Ambarella, Inc. Announces Third Quarter Fiscal 2015 Financial Results investment picks
2014/12/10
GREEN BAY, Wis.
Sign-up for Associated Banc-Corp Announces Transfer Listing to NYSE investment picks
2014/12/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163974&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for ADP Regional Employment Report: All Four Major Regions Add Fewer Jobs in November Than Previous Six-Month Average investment picks
2014/12/10
MCLEAN, Va.
Sign-up for WidePoint Receives $4.5 Million Option Year Exercise From a Federal Agency Customer investment picks
2014/12/10
GE Global Research and GE Energy Consulting, along with National Grid, the Department of Energy (DOE) National Renewable Energy Laboratory (NREL), and Clarkson University today announced a partnership on a research project to improve the reliability and resiliency of electricity delivery in northern New York.
Sign-up for GE, Utility, Government, and Academia Partner on Underground Microgrid Project to Improve Electricity Reliability in NY’s North Country investment picks
2014/12/10
Granite Construction Incorporated (NYSE:GVA) announced that the joint-venture team comprised of Granite Construction Company and Pulice Construction, Inc. has been awarded a $109 million design/build contract by the Arizona Department of Transportation to reconstruct 19 miles of State Route 202 in Phoenix.
Sign-up for Granite on Joint Venture Team to Construct $109 Million Highway Improvement Project in Arizona investment picks
2014/12/10
KILGORE, Texas, Dec.
Sign-up for Martin Midstream Partners L.P. Announces Upcoming Company Presentation investment picks
2014/12/11
DUBLIN , Dec.
Sign-up for Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC investment picks
2014/12/12
ADVISORY, Dec.
Sign-up for HealthCare Chaplaincy Network to Ring The Nasdaq Stock Market Closing Bell investment picks
2014/12/10
On Wednesday, December 10, 2014, Medinah Minerals, Inc. (OTC Pink: MDMN) reports that its 100% owned Chilean subsidiary, Medinah Mining Chile, was informed by Compania NUOCO Mining Chile SCM as follows: Compania NUOCO Mining Chile SCM has received a formal Letter of Intent from AURYN Mining Chile, SpA to acquire all of NUOCO’s claims holdings which include the Las Dos Marias claims, the Los Amigos claims, Columbo and Mambo claims.
Sign-up for Medinah Mining Chile Confirms that Compania NUOCO Mining Chile SCM has Received a Formal Letter of Intent Proposal with Regard to Its Entire Ownership Interest in Property Claims in Chile investment picks
2014/12/11
"Birdman," the feature film about a washed-up actor who tries to reclaim past glory by directing a Broadway play, and "Fargo," FX's miniseries that reconstitutes the hit 1996 film, led all prospects in Golden Globe nominations on Thursday.
Sign-up for UPDATE: CORRECT: 'Birdman,' 'Fargo' lead Golden Globe nods investment picks
2014/12/11
BALTIMORE , Dec.
Sign-up for T. Rowe Price Group Announces Increase In Stock Repurchase Authorization investment picks
2014/12/5
CHARLOTTE, N.C. , Dec.
Sign-up for UTC Aerospace Systems provides critical control systems for NASA's Orion spacecraft launched today investment picks
2014/12/6
93% (13/14) of evaluable CLL patients treated at dose levels ≥ 800mg of original formulation or any dose of the micronized formulation achieved a > 50% reduction in nodal size (a nodal PR) and 50% (7/14) achieved a partial response per iwCLL (Hallek 2008) criteria 100% (6/6) of CLL and iNHL patients achieving TGR-1202 drug concentrations above 4,000ng/ml responded at the first or second efficacy assessment with at least a nodal PR for CLL or PR for iNHL; Expansion cohorts now open at 800mg QD for CLL and 1200mg QD for iNHL, the dose level that appears to provide patients (3/3) with drug concentrations > 4,000ng/ml No drug related hepatic toxicity or colitis observed with 55 patients treated to date and median time on study of approximately 6 months and some patients on study for over 1.5 years TGR-1202 has been well-tolerated with no dose-related trends in adverse events observed and no MTD reached to date, dose escalation continues now at 1800mg QD SAN
Sign-up for Interim Data From Phase 1 Dose Escalation Clinical Trial of TGR-1202, the Once-Daily PI3K Delta Inhibitor, Demonstrates Significant Clinical Activity and Lack of Hepatic Toxicity in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma investment picks
2014/12/4
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) announced today that it will release its 2014 fourth quarter and year-end financial results on Wednesday, December 17, 2014, before the market opens.
Sign-up for Eagle Pharmaceuticals to Discuss 2014 Fourth Quarter and Year-End Financial Results on December 17, 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: QAD to Conduct One-on-One Investor Meetings at Benchmark Micro Cap Discovery Conference to Eagle Pharmaceuticals to Discuss 2014 Fourth Quarter and Year-End Financial Results on December 17, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent